Sold as Levaquin, Levaquin In Dextrose 5% In Plastic Container, Quixin, Iquix. Every FDA application for this active ingredient: 5 branded and 45 generic.
As of Nov 16, 2026, FDA lists 50 applications for Levofloxacin (sold as Levaquin, Levaquin In Dextrose 5% In Plastic Container, Quixin and others), first approved Dec 20, 1996, with 32 new uses approved and 0 published complete response letters.
| Levofloxacin | Part D | $17.1M | +15% | 1,851,365 |
| Levofloxacin | Part B | $8K | +22% | 554 |
| Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral Follow-up Treatment in Febrile Urinary Tract Infections in Men Caused by Susceptible EnterobacteriaProstatitis, Escherichia Coli Infection · Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Nov 12, 2026 |
| All-Oral Fluoroquinolone-Based Triple Therapies for Adults With Imaging-Confirmed Osteoarticular BrucellosisBrucellosis, Osteoarticular Brucellosis · The First Affiliated Hospital of Shihezi University | Not applicable | Not yet recruiting | Oct 21, 2026 |
| Fluoroquinolone-Doxycycline Oral Treatments for Adults With Uncomplicated BrucellosisBrucellosis · The First Affiliated Hospital of Shihezi University | Not applicable | Not yet recruiting | Oct 21, 2026 |
| Efficacy and Safety of Piclosept in the Complex Treatment of Neonatal DacryocystitisNeonatal Dacryocystitis, Congenital Nasolacrimal Duct Obstruction · Kazakh Eye Research Institute | Phase 4 | Active, not recruiting | Oct 15, 2026 |
| European Implementation Study on Simultaneous Screening for Gastric and Colorectal CancersHelicobacter Pylori Infection, Colorectal Cancer · University of Latvia | — | Not yet recruiting | Oct 14, 2026 |
| A Phase 2b Study to Evaluate the Efficacy, Safety, and PK Profiles of TNP-2092 Administered Via IA Injection in PJI ParticipantsProsthetic Joint Infection (PJI) · TenNor Therapeutics (Zhongshan) Limited | Phase 2 | Recruiting | Oct 5, 2026 |
| Intracameral Levofloxacin Versus Moxifloxacin After Cataract SurgeryCataract, Postoperative Endophthalmitis · Assiut University | Not applicable | Not yet recruiting | Sep 30, 2026 |
| Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired PneumoniaCommunity-acquired Pneumonia, CAP · Copenhagen Respiratory Research | Phase 2 / Phase 3 | Active, not recruiting | Sep 25, 2026 |
| Dec 20, 1996 | LevaquinNDA 20634 · New dosage form | Janssen Pharms | 64 | Discontinued |
| Dec 20, 1996 | Levaquin, Levaquin In Dextrose 5% In Plastic ContainerNDA 20635 · New dosage form | Janssen Pharms | 57 | Discontinued |
| Aug 18, 2000 | QuixinNDA 21199 · New dosage form | Santen | 6 | Discontinued |
| Mar 1, 2004 | IquixNDA 21571 · New dosage form | Santen | 1 | Discontinued |
| Oct 21, 2004 | LevaquinNDA 21721 · New dosage form | Janssen Pharms | 26 | Discontinued |
| Dec 20, 2010 | LevofloxacinANDA 78282 | Rubicon Research | 1 | Marketed |
| Dec 20, 2010 | LevofloxacinANDA 77700 | Rising | 0 | Marketed |
| Dec 20, 2010 | LevofloxacinANDA 90268 | Sciegen Pharms | 1 | Discontinued |
| Feb 10, 2011 | LevofloxacinANDA 76826 | Watson Labs Teva | 1 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 76710 | Dr Reddys Labs Inc | 14 | Marketed |
| Jun 20, 2011 | LevofloxacinANDA 90367 | Chartwell Rx | 5 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 91644 | Rising | 6 | Marketed |
| Jun 20, 2011 | LevofloxacinANDA 91678 | Novitium Pharma | 7 | Marketed |
| Jun 20, 2011 | LevofloxacinANDA 200560 | Pharmobedient | 9 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 90722 | Torrent Pharms | 12 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 76361 | Teva | 13 | Marketed |
| Jun 20, 2011 | LevofloxacinANDA 77097 | Natco Pharma | 9 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 77438 | Sandoz | 15 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 78424 | Lupin | 14 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 201043 | Aurobindo Pharma Ltd | 16 | Marketed |
| Jun 20, 2011 | LevofloxacinANDA 76276 | Natco Pharma | 9 | Discontinued |
| Jun 20, 2011 | LevofloxacinANDA 200250 | Glenmark Pharms Ltd | 6 | Marketed |
| Jul 7, 2011 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 90343 | Inforlife | 11 | Marketed |
| Sep 16, 2011 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 91375 | Hikma Farmaceutica | 9 | Marketed |
| Sep 29, 2011 | LevofloxacinANDA 90787 | Apotex Inc | 13 | Discontinued |
| Jan 30, 2012 | LevofloxacinANDA 202200 | Orbion Pharms | 11 | Marketed |
| Mar 22, 2012 | LevofloxacinANDA 200839 | Macleods Pharms Ltd | 15 | Marketed |
| Mar 30, 2012 | LevofloxacinANDA 76890 | Chartwell Molecular | 11 | Marketed |
| Sep 7, 2012 | LevofloxacinANDA 77652 | Zydus Lifesciences | 11 | Marketed |
| Jan 24, 2013 | LevofloxacinANDA 202590 | Avet Lifesciences | 7 | Discontinued |
| Jan 24, 2013 | LevofloxacinANDA 202328 | Eugia Pharma | 8 | Discontinued |
| Jun 5, 2013 | LevofloxacinANDA 91436 | Baxter Hlthcare Corp | 8 | Discontinued |
| Jun 19, 2013 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 200674 | Fresenius Kabi USA | 6 | Marketed |
| Aug 8, 2013 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 91397 | Baxter Hlthcare Corp | 9 | Discontinued |
| Nov 22, 2013 | LevofloxacinANDA 201484 | Watson Labs Inc | 0 | Discontinued |
| Jan 8, 2015 | LevofloxacinANDA 202801 | Hetero Labs Ltd V | 6 | Marketed |
| Jun 19, 2015 | LevofloxacinANDA 203613 | Jubilant Generics | 4 | Discontinued |
| Aug 12, 2015 | LevofloxacinANDA 78577 | Hospira | 0 | Discontinued |
| Sep 3, 2015 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 78579 | Hospira | 5 | Marketed |
| Feb 10, 2016 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 206919 | Eugia Pharma | 5 | Discontinued |
| Jun 1, 2017 | LevofloxacinANDA 205968 | Zydus Pharms | 3 | Discontinued |
| Dec 8, 2017 | LevofloxacinANDA 204899 | Pharmobedient | 0 | Discontinued |
| May 25, 2018 | LevofloxacinANDA 205222 | Lannett Co Inc | 1 | Marketed |
| Feb 5, 2019 | LevofloxacinANDA 204968 | Hec Pharm | 1 | Marketed |
| Feb 27, 2019 | LevofloxacinANDA 205600 | Micro Labs Ltd India | 1 | Discontinued |
| Apr 22, 2020 | LevofloxacinANDA 205540 | Gland | 1 | Marketed |
| Dec 30, 2020 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 206908 | Gland | 1 | Marketed |
| Jan 29, 2024 | Levofloxacin In Dextrose 5% In Plastic ContainerANDA 216164 | Knack | 1 | Discontinued |
| — | LevofloxacinANDA 78767 | Hikma Pharms | 0 | Discontinued |
| — | LevofloxacinANDA 90063 | Mylan Pharma | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA